This trial is active, not recruiting.

Conditions thyroid disease, parathyroid disease, endocrine gland
Sponsor University of Arkansas
Start date January 2010
End date December 2016
Trial size 1000 participants
Trial identifier NCT01539499, 112685


The goal of this study is to help better determine the complication rates for endocrine surgery across the nation for both benign and malignant disease. It is our hypothesis that the complication rates are low overall and that malignant disease results in a higher complication rate than benign disease. This study will do a database review from all University HealthSystem Consortium (UHC).

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model case-only
Time perspective retrospective

Primary Outcomes

Complication Rates for Endocrine Surgery
time frame: baseline

Eligibility Criteria

Male or female participants from 18 years up to 90 years old.

Inclusion Criteria: - All patients between the ages of 18 and 90 years who have a diagnosis of benign multinodular goiter and/or malignant thyroid disease and have undergone a total thyroidectomy as a primary procedure. - Parathyroid patients will also be studied. Exclusion Criteria: - Non endocrine surgery patients

Additional Information

Official title Complications of Endocrine Surgery: Data From the United Health System Consortium
Principal investigator Brendan Stack, MD
Trial information was received from ClinicalTrials.gov and was last updated in July 2016.
Information provided to ClinicalTrials.gov by University of Arkansas.